Concepedia

Benjamin F. Springer

BF

3

Publications

144

Citations

3

H-Index

2022

Active since

Affiliations

Dana-Farber Brigham Cancer Center(Current)

Brigham and Women's Hospital

Benjamin F. Springer is an author at Dana-Farber Brigham Cancer Center specializing in tumor biology, medicine, and lung cancer.

ORCID

Top concepts

Publications per year

2022–2023

3

Publications

3

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer

Shunsuke Kitajima, Tetsuo Tani, Benjamin F. Springer et al. · Cancer Cell · 2022 · 90 citations · Full text

, , +4

MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer

Ryohei Yoshida, Maria Saigí, Tetsuo Tani et al. · Cancer Research · 2022 · 33 citations · Full text

Aurora A kinase inhibition induces accumulation of SCLC tumor cells in mitosis with restored interferon signaling to increase response to PD-L1

Yixiang Li, Navin R. Mahadevan, Leslie Duplaquet et al. · Cell Reports Medicine · 2023 · 21 citations · Full text

, , +23

Rows per page

1–3 of 3